Ibrahima Ndiaye

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

B Ndiaye, Friedrich Thienemann, Martin O. C. Ota et al. · The Lancet Respiratory Medicine · 2015 · 163 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

Jean Louis Ndiaye, Milijaona Randrianarivelojosia, Issaka Sagara et al. · Malaria Journal · 2009 · 93 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal

Navin Venkatraman, B Ndiaye, Georgina Bowyer et al. · The Journal of Infectious Diseases · 2018 · 83 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

HIV Prevention Among Male Clients of Female Sex Workers in Kaolack, Senegal: Results of a Peer Education Program

Lori Leonard, Ibrahima Ndiaye, Asha S. Kapadia et al. · AIDS Education and Prevention · 2000 · 68 citations

Public Health, Health Education, Health Promotion +17

Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Jean Louis Ndiaye, Babacar Faye, Ali Gueye et al. · Malaria Journal · 2011 · 66 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15